Zolpidem Tartrate Sublingual Tablet
Product Images NDC 49884-898

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate Sublingual (NDC 49884-898). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 1)

Chemical structure of zolpidem tartrate, showing the molecular components and arrangement of the active ingredient in the zolpidem tartrate sublingual tablet product by Par Health USA, LLC.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 10)

Label for Zolpidem Tartrate Sublingual Tablet 3.5 mg showing the dosage strength prominently. The label includes the NDC number (49884-899-52), instructions to push the tablet through the blister from the other side, and the distributor Par Pharmaceutical located in Chestnut Ridge, NY. The tablet is made in India and marked as a Schedule IV controlled substance.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 11)

Zolpidem tartrate sublingual tablet 1.75 mg tablet package label showing dosing instructions. The label includes the proprietary name Zolpidem Tartrate Sublingual Tablet, strength 1.75 mg, sublingual route, and directions with dosing time chart. Distributor is Par Pharmaceutical, and manufacturer is Par Formulations Private Limited, India. The label instructs to keep the drug out of reach of children, for sublingual use only, and not to swallow the tablet whole. The package contains 1 sublingual tablet.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 12)

This label is for Zolpidem Tartrate Sublingual Tablet 3.5 mg, a prescription sublingual tablet marketed by Par Health USA, LLC. The label includes dosing information, expiration and lot number space, storage instructions, warnings about swallowing, and a dosing time chart to guide administration. The product is distributed by Par Pharmaceutical and manufactured by Par Formulations Private Limited.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 13)

Packaging label for Zolpidem Tartrate Sublingual Tablet 1.75 mg by Par Health USA, LLC. The label indicates 30 unit-dose pouches, each containing one sublingual tablet. Instructions emphasize sublingual administration only and direct pharmacists to dispense with a medication guide and dosing time tool. The label includes storage and dosage information, barcode, and manufacturing details.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 14)

Packaging label for Zolpidem Tartrate Sublingual Tablet 3.5 mg by Par Health USA, LLC. The carton includes 30 unit-dose pouches, each containing one sublingual tablet. Label indicates Rx only, with instructions for sublingual use only and to read the medication guide before use. Storage information and a barcode are also visible.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 15)

Dosage timing instruction illustration for Zolpidem Tartrate Sublingual Tablet displays a circular time wheel labeled with 12-hour clock times from 12:00 to 11:30, marked by green and black text and arrows indicating to turn the wheel. Adjacent text explains how to use the wheel to find the latest dosing time by aligning the earliest wake time under a green arrow and dosing time under a brown arrow, with warnings to only take the tablet if at least 4 hours of bedtime remain.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 2)

An illustration showing a person sleeping with an alarm clock and a labeled pouch on a bedside table. The label indicates 'only 1 pouch,' emphasizing the quantity to be used or kept by the bedside.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 3)

A table listing recommended times to take zolpidem tartrate sublingual tablets, correlating the time by which the user must be awake with the latest time to take the medication. It pairs specific wake times from 4 am to 9 am with corresponding medication times from 12 midnight to 5 am.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 4)

An instructional diagram for Zolpidem Tartrate Sublingual Tablet showing timing guidelines. It advises the patient to take the tablet before 12:00 am and to be awake by 4:00 am. Instructions include using a wheel to find the latest dosing time by aligning the earliest awake time under a green arrow and the bedtime before under a brown arrow. It notes the tablet should be taken only if at least 4 hours of bedtime remains.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 5)

An instructional diagram labeled Figure D showing how to open a pouch. It illustrates folding along a dotted line as step 1 and tearing open at a notch at the center of the dotted line as step 2.*

FDA Label Image

Zoplidem (Zolpidem Tartrate Sublingual Tablets 6)

An instructional line drawing showing two hands manipulating a small object. The image likely demonstrates how to handle or open a dosage form, relevant to Zolpidem tartrate sublingual tablets by Par Health USA, LLC. It is labeled as Figure E.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 7)

Illustration labeled Figure F showing a tabletop with an analog clock and an empty pouch indicated by an arrow labeled 'empty pouch.' The image appears to depict a timing or disposal instruction related to the use of a medication pouch.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 8)

Instructional illustration showing a hand placing a Zolpidem tartrate sublingual tablet under the tongue for sublingual administration. The mouth is open with the tablet positioned beneath the tongue.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 9)

Zolpidem Tartrate Sublingual Tablet 1.75 mg label showing dosage form as sublingual tablet. The label includes directions to push the tablet through the blister from the other side. Distributed by Par Pharmaceutical in Chestnut Ridge, NY, made in India. Barcode and NDC 49884-898-52 are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.